Illuminating the Path for Novel Peripheral Drug-Eluting Stents.
Secemsky, Eric A, and Ajar Kochar. 2022. “Illuminating the Path for Novel Peripheral Drug-Eluting Stents.”. JACC. Cardiovascular Interventions 15 (6): 627-29.
Search
Search results
13389 results found
Intravascular ultrasound guidance for lower extremity arterial and venous interventions.
Secemsky, Eric A, Sahil A Parikh, Maureen Kohi, Michael Lichtenberg, Mark Meissner, Ramon Varcoe, Andrew Holden, et al. 2022. “Intravascular Ultrasound Guidance for Lower Extremity Arterial and Venous Interventions.”. EuroIntervention : Journal of EuroPCR in Collaboration With the Working Group on Interventional Cardiology of the European Society of Cardiology 18 (7): 598-608.
Drug-coated balloons in the real world: do they hold up?
Secemsky, Eric A, and Serge Korjian. 2022. “Drug-Coated Balloons in the Real World: Do They Hold Up?”. EuroIntervention : Journal of EuroPCR in Collaboration With the Working Group on Interventional Cardiology of the European Society of Cardiology 18 (11): e870-e871.
National trends in utilization of thrombolytic therapy for acute pulmonary embolism.
Beyer, Sebastian E, Colby Shanafelt, Duane S Pinto, Jeffrey L Weinstein, Jay Giri, Akhilesh K Sista, Robert W Yeh, Eric A Secemsky, and Brett J Carroll. 2022. “National Trends in Utilization of Thrombolytic Therapy for Acute Pulmonary Embolism.”. Vascular Medicine (London, England) 27 (1): 75-76.
Interhospital Transfer for the Management of Acute Pulmonary Embolism.
Carroll, Brett J, Sebastian E Beyer, Colby Shanafelt, Christopher Kabrhel, Parth Rali, Belinda Rivera-Lebron, Rachel Rosovsky, Charles B Ross, Duane S Pinto, and Eric A Secemsky. 2022. “Interhospital Transfer for the Management of Acute Pulmonary Embolism.”. The American Journal of Medicine 135 (4): 531-35.
Impact of malnutrition and frailty on mortality and major amputation in patients with CLTI.
Karim, Adham M, Jun Li, Muhammad S Panhwar, Samiullah Arshad, Shihabaldean Shalabi, Carlos Mena-Hurtado, Herbert D Aronow, Eric A Secemsky, and Mehdi H Shishehbor. 2022. “Impact of Malnutrition and Frailty on Mortality and Major Amputation in Patients With CLTI.”. Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions 99 (4): 1300-1309.
Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials).
Secemsky, Eric A, Alexis Matteau, Robert W Yeh, Philippe Gabriel Steg, Edoardo Camenzind, William Wijns, Eugene McFadden, Laura Mauri, and PROTECT Trial Investigators. 2015. “Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials).”. The American Journal of Cardiology 115 (12): 1678-84.
Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
Secemsky, Eric A, Robert W Yeh, Dean J Kereiakes, Donald E Cutlip, Gabriel Steg, Joseph M Massaro, Patricia K Apruzzese, Laura Mauri, and Dual Antiplatelet Therapy Study Investigators. 2017. “Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.”. JACC. Cardiovascular Interventions 10 (9): 942-54.
Correlating the Dermatology Life Quality Index and Skin Discoloration Impact Evaluation Questionnaire tools in disorders of hyperpigmentation.
Maymone, Mayra B C, Hind H Neamah, Eric A Secemsky, and Neelam A Vashi. 2018. “Correlating the Dermatology Life Quality Index and Skin Discoloration Impact Evaluation Questionnaire Tools in Disorders of Hyperpigmentation.”. The Journal of Dermatology 45 (3): 361-62.
Brachial-ankle pulse wave velocity as a marker of adverse events following non-ST-elevation myocardial infarction: a new standard in risk stratification?
Secemsky, Eric A, and Robert W Yeh. 2017. “Brachial-Ankle Pulse Wave Velocity As a Marker of Adverse Events Following Non-ST-Elevation Myocardial Infarction: A New Standard in Risk Stratification?”. Coronary Artery Disease 28 (8): 634-35.